Jump to content

Alloclamide

From Wikipedia, the free encyclopedia
Alloclamide
Clinical data
Trade namesPectex, Tuselin
Identifiers
  • 2-(Allyloxy)-4-chloro-N-[2-(diethylamino)ethyl]benzamide
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H23ClN2O2
Molar mass310.82 g·mol−1
3D model (JSmol)
  • CCN(CC)CCNC(=O)C1=C(C=C(C=C1)Cl)OCC=C
  • InChI=1S/C16H23ClN2O2/c1-4-11-21-15-12-13(17)7-8-14(15)16(20)18-9-10-19(5-2)6-3/h4,7-8,12H,1,5-6,9-11H2,2-3H3,(H,18,20)
  • Key:UHWFVIPXDFZTFA-UHFFFAOYSA-N

Alloclamide (Pectex, Tuselin) is an antitussive and antihistamine drug marketed in Finland and Spain. It has never been marketed in the US.

It is sold as an oral solution, containing 6.25 mg/mL alloclamide. The recommended dosage for adults is 25 mg three to four times daily. Adverse effects include constipation and sedation.[1]

References

[edit]
  1. ^ Schlesser JL (1991). Drugs Available Abroad, 1st Edition. Derwent Publications Ltd. p. 6. ISBN 0-8103-7177-4.